Ananworanich J, Mogg R, Dunne MW, Bassyouni M, et al. Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19. Clin Infect Dis 2021 Sep 15. pii: 6370549. doi: 10.1093.
PMID: 34523673